RegWardenFDA facility compliance records
Recall

Class II — Magellan Diagnostics, Inc.

Recalling firmMAGELLAN Diagnostics INC.
Registered facilityMagellan Diagnostics, Inc. (the firm's only registered facility)
ClassificationClass II
StatusOngoing
ReasonCalibration Buttons being used in the kitting process were incorrectly labeled as Lot 2323M for lot 2333M. The use of mislabeled calibration Button with Lot #2333 can lead to delayed or erroneous high or erroneous low results.
ProductThe LeadCare® II Blood Lead Test System relies on electrochemistry and a unique Sensor to detect lead in whole blood. The LeadCare® II Test Kit is provided with the following materials: " Sensors (2 Containers of 24 sensors each; 48 tests) " Treatment Reagent Tubes (2 packages of 24 tubes each; 48 tests) " Heparinized Capillary Tubes/Plungers (50) " Transfer Droppers (50) " Calibration Button (1) " Lead Control Level 1 (1 @ 2 mL) " Lead Control Level 2 (1 @ 2 mL)
Quantity1,774 units
DistributionUS Nationwide distribution.
Initiated2024-02-23
Classified2025-11-21
Recall numberZ-0584-2026
InitiationVoluntary: Firm initiated

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)

Cite this record

RegWarden. “Class II recall — Magellan Diagnostics, Inc. (Z-0584-2026).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/97858/

Not open yet

Alerts for MAGELLAN Diagnostics INC.

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.